Hi all, Unfortunately, some of us are old enough to remember 3+...

Hi all,

Unfortunately, some of us are old enough to remember 3+ decades ago a young (ish) Jack Thompson spruiking on TV a non-alcoholic drink called Claytons. I paid attention to the ad mainly because it was filmed at on of my regular haunts, the Woollahra pub in Paddo (Syd). But its main punch line was ..."the drink you have when not having a drink".

So this is the Clayton's deal....the deal you have when not having a deal.

We (and management) know that this deal is not what was expected and will not result in any short-medium term value accretion to SUD. Quite frankly, Amherst (a private nano coy with no sales) and its owner, Ira Wiesberg really don't have any muscle/credibility to really shift SUD 002 into any meaningful commercialisation process and Amhurst's Zolpimist has been FDA approved for more than 6 years and still no sales through their contracted manufacturer/marketer, Hi Tech Pharmacal? Hhmmm, sounds more like a dead rubber swap; little/no outcome for little/no outcome.

But this certainly isn't the deal that highly respected consultants, Torreya Partners have been working toward. It must be a smokescreen. Where are the Artimist and in-house trade sale deals that have been spruiked since 9 May 2014? In the AGM...only 7 weeks ago, they said 11 coys in CA/due diligence; what has happened to them and the process?

I know from experience that deals of these types never go according to expectations, especially when you are the price taker and a nano in among giants. But surely its time to professionally acknowledge at least 4 things:

1) SUD have been misleading to the market (or at least grossly wrong) in managing its shareholders expectations,
2) SUD need to undertake a reality check of their limitations/capabilities to successfully complete a deal among giants
3) SUD need to be much more realistic and open with information,
4) Show some respect for shareholders; they are intelligent adults, not vacuous children that can be diverted by continually deferred (and broken?) promises.

Time to come clean, admit mistakes, reformulate, communicate with shareholders, action, make squillions.

Simples.

But come clean...and very soon. Don't let the remaining shareholder support melt away.

Cheers,